Analyst Ratings for Anadys Pharmaceuticals (ANDS)

ANDS Rating Summary

  |   Expand Research on ANDS
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 0 / 10   Percentile Rank: 0%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/14/2011 William Blair N/A Downgrade Market Perform
(N/A)		 4.00
(N/A)		 3.64
(3.70)		 1.65% Details
10/18/2011 Noble Capital N/A Downgrade Underperform
(N/A)		 3.50
(N/A)		 3.65
(3.70)		 1.37% Details